Iliopsoas Abscesses: Whose Problem is it? Insights Gained by an Institutional 100-Patient Consecutive Case Series. Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

abstract

  • BACKGROUND: Iliopsoas abscess (IPA) is a rare but serious condition caused by hematogenous or contiguous spread of infection. Management typically involves broad-spectrum antibiotics, with percutaneous or surgical drainage for larger abscesses. METHODS: We retrospectively reviewed 113 IPA cases at the Swedish Neuroscience Institute (2015-2024), analyzing demographics, clinical features, imaging, treatment strategies, hospital course, and outcomes. RESULTS: Among 100 patients included, 86 presented with back or flank pain, 45 with abdominal pain, and 35 with lower extremity discomfort. The most common pathogens were Staphylococcus aureus (38%) and Escherichia coli (31%). Mean patient age was 56 years (range: 32-71); 29% had intra-abdominal inflammatory disease, 25% had bacteremia, and 32% were intravenous drug users. Antibiotics alone were successful in 16/21 patients (76%), while 5 (24%) required subsequent CT-guided percutaneous drainage (PCD). Among 72 patients undergoing PCD, 32 (44%) had successful treatment, 12 (17%) required multiple procedures, and 28 (39%) underwent surgery after failed drainage. Primary surgical drainage was performed in 7 patients (7%). Mean hospital stay was 21 days, and overall mortality was 5%, lower than reported rates (5%-15%). CONCLUSIONS: First-line treatment for IPA includes antibiotics and PCD, with surgery reserved for complex cases, gas formation, neurological involvement, proximity to vertebrae or spinal hardware, or failure of initial treatment.

authors

  • Hamade, Youssef J
  • Ogando-Rivas, Elizabeth
  • Tataryn, Zachary L
  • Costa, Matias L
  • Al-Khalili, Kenan
  • Yeung, Toching
  • Pluemer, Jonathan
  • Robinson, Jerry E
  • Abdul-Jabbar, Amir
  • Kasper, Ekkehard
  • Oskouian, Rod J
  • Chapman, Jens R

publication date

  • April 14, 2025